9NTG | pdb_00009ntg

Helix pomatia AMP deaminase (HPAMPD) in complex with Pentostatin

  • Classification: HYDROLASE
  • Organism(s): Helix pomatia
  • Expression System: Komagataella pastoris
  • Mutation(s): No 

  • Deposited: 2025-03-18 Released: 2025-06-18 
  • Deposition Author(s): Kaur, G., Horton, J.R., Cheng, X.
  • Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS), Cancer Prevention and Research Institute of Texas (CPRIT)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.63 Å
  • R-Value Free: 
    0.182 (Depositor), 0.182 (DCC) 
  • R-Value Work: 
    0.156 (Depositor), 0.156 (DCC) 
  • R-Value Observed: 
    0.158 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9NTG

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Structural basis for the substrate specificity of Helix pomatia AMP deaminase and a chimeric ADGF adenosine deaminase.

Kaur, G.Horton, J.R.Tzertzinis, G.Zhou, J.Schildkraut, I.Cheng, X.

(2025) J Biological Chem 301: 110357-110357

  • DOI: https://doi.org/10.1016/j.jbc.2025.110357
  • Primary Citation Related Structures: 
    9NTE, 9NTF, 9NTG, 9NTH, 9NTI, 9NTJ, 9NTK

  • PubMed Abstract: 

    Helix pomatia AMP deaminase (HPAMPD), an enzyme enriched in the foot muscle of the mollusk Helix pomatia, exhibits deaminase activity on adenosine-5'-monophosphate (AMP). HPAMPD is the first member of the adenosine deaminase-related growth factor (ADGF) family to prefer the nucleotideAMP over the nucleoside adenosine. To investigate the substrate selectivity of HPAMPD, we determined its structure in both the apo form and in complex with the adenosine analogs pentostatin and pentostatin-5'-monophosphate. Structurally, HPAMPD adopts a fold similar to human ADA2, an ADGF family member. HPAMPD has acquired the ability to interact with the 5'-monophosphate group of AMP through polar and charged residues located in three key structural elements: (1) the loop immediately following strand β1; (2) the loop between helices αH and αI; and (3) the end of strand β5 and its adjacent loop. We engineered a chimeric deaminase by integrating these elements from HPAMPD into another related mollusk nucleoside adenosine deaminase, Aplysia ADGF. The chimeric enzyme efficiently deaminates AMP, demonstrating a gained substrate specificity, while retaining the adenosine deamination activity of Aplysia ADGF. The phosphate-binding feature of HPAMPD is a hallmark of nucleotide deaminases, conserved among AMP and N6-methyl-AMP (6mAMP) deaminases. We discuss the human adenosine deaminases each with distinct substrate specificities for the nucleoside, the nucleotide (AMP), and its methylated form, 6mAMP.


  • Organizational Affiliation
    • Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Macromolecule Content 

  • Total Structure Weight: 253.67 kDa 
  • Atom Count: 18,921 
  • Modeled Residue Count: 1,996 
  • Deposited Residue Count: 2,164 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Helix pomatia AMP deaminase
A, B, C, D
541Helix pomatiaMutation(s): 0 

Oligosaccharides

Help  
Entity ID: 2
MoleculeChains Length2D Diagram GlycosylationD Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
E
2N-Glycosylation
Glycosylation Resources
GlyTouCan: G42666HT
GlyCosmos: G42666HT
GlyGen: G42666HT

Small Molecules

Ligands 5 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
DCF
(Subject of Investigation/LOI)

Query on DCF



Download:Ideal Coordinates CCD File
CC [auth D],
LB [auth C],
UA [auth B],
V [auth A]
2'-DEOXYCOFORMYCIN
C11 H16 N4 O4
FPVKHBSQESCIEP-JQCXWYLXSA-N
NAG

Query on NAG



Download:Ideal Coordinates CCD File
F [auth A]
G [auth A]
H [auth A]
I [auth A]
MB [auth D]
F [auth A],
G [auth A],
H [auth A],
I [auth A],
MB [auth D],
NB [auth D],
OB [auth D],
PB [auth D],
VA [auth C],
W [auth B],
WA [auth C],
X [auth B],
XA [auth C],
Y [auth B],
Z [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
BTB

Query on BTB



Download:Ideal Coordinates CCD File
JA [auth B],
N [auth A]
2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL
C8 H19 N O5
OWMVSZAMULFTJU-UHFFFAOYSA-N
ZN

Query on ZN



Download:Ideal Coordinates CCD File
AA [auth B],
J [auth A],
QB [auth D],
YA [auth C]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
AB [auth C]
AC [auth D]
BA [auth B]
BB [auth C]
BC [auth D]
AB [auth C],
AC [auth D],
BA [auth B],
BB [auth C],
BC [auth D],
CA [auth B],
CB [auth C],
DA [auth B],
DB [auth C],
EA [auth B],
EB [auth C],
FA [auth B],
FB [auth C],
GA [auth B],
GB [auth C],
HA [auth B],
HB [auth C],
IA [auth B],
IB [auth C],
JB [auth C],
K [auth A],
KA [auth B],
KB [auth C],
L [auth A],
LA [auth B],
M [auth A],
MA [auth B],
NA [auth B],
O [auth A],
OA [auth B],
P [auth A],
PA [auth B],
Q [auth A],
QA [auth B],
R [auth A],
RA [auth B],
RB [auth D],
S [auth A],
SA [auth B],
SB [auth D],
T [auth A],
TA [auth B],
TB [auth D],
U [auth A],
UB [auth D],
VB [auth D],
WB [auth D],
XB [auth D],
YB [auth D],
ZA [auth C],
ZB [auth D]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.63 Å
  • R-Value Free:  0.182 (Depositor), 0.182 (DCC) 
  • R-Value Work:  0.156 (Depositor), 0.156 (DCC) 
  • R-Value Observed: 0.158 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 76.128α = 90
b = 81.983β = 92.265
c = 212.016γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
autoPROCdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR35GM134744
Cancer Prevention and Research Institute of Texas (CPRIT)United StatesRR160029

Revision History  (Full details and data files)

  • Version 1.0: 2025-06-18
    Type: Initial release
  • Version 1.1: 2025-12-31
    Changes: Database references